Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NYXH
#3846
Nyxoah SA Ordinary Shares
3.3
8
USD
+3.36%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+3.36%
Monthly Change
+7.64%
6 month change
-43.48%
Year Change
-42.42%
Previous Close
3.2
7
Open
3.3
9
Bid
Ask
Low
3.3
8
High
3.3
9
Volume
2
Markets
US Stock Market
Healthcare
NYXH
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
25.77 M
25.85 M
28.67 M
37.43 M
43.03 M
134.97 M
Valuation ratios
Enterprise value
592.76 M
136.73 M
135.48 M
299.42 M
197.92 M
769.55 M
Price to earnings ratio
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
—
—
—
—
—
—
Return on equity %
—
—
—
—
—
—
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
—
—
—
—
—
—
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
—
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
—
Working capital per share
—
—
—
—
—
—
Book value per share
—
—
—
—
—
—
News
Nyxoah SA (NYXH) Q4 2025 Earnings Call Transcript
Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates
Nyxoah at Oppenheimer Conference: Strategic U.S. Launch Focus
KORU Medical Systems, Inc. (KRMD) Reports Q4 Loss, Beats Revenue Estimates
Veeva Systems (VEEV) Q4 Earnings and Revenues Surpass Estimates
Nyxoah SA (NYXH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Stifel reiterates Buy rating on Nyxoah stock, maintains $12 price target
Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System
Inspire Medical Systems stock soars after Medicare reimbursement boost
Piper Sandler lowers Nyxoah stock price target to $9 from $12
Nyxoah SA (NYXH) Reports Q3 Loss, Beats Revenue Estimates
Nyxoah secures up to $77 million in financing for Genio commercialization